CHIMERIC ANTIGEN RECEPTOR-MODIFIED GRANULOCYTE-MACROPHAGE PROGENITORS FOR CANCER IMMUNOTHERAPY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240240147A1
SERIAL NO

18561889

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure provides methods to genetically engineer granulocyte-macrophage progenitors (GMPs) to express a chimeric antigen receptor (CAR), and uses thereof, including for cancer immunotherapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF SOUTHERN CALIFORNIA1150 SOUTH OLIVE STREET SUITE 2300 LOS ANGELES CA 90015

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jing, Xueyuan Los Angeles, US 1 0
Ying, Qi-Long Los Angeles, US 11 117
Yue, Shi Los Angeles, US 5 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation